PA
PALI.V
—
TSX Venture
Financial & Commodity Market Operators & Service Providers
Palisades Goldcorp Ltd.
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
87,4 %
ROE
59,7 %
Net margin
71,6 %
Debt / equity
0,04
Beta
—
52w range
—
Volume
13,7k
Day range
$2,05–$2,15
Prev close
$2,07
Open
$2,05
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About
PALI.V operates in the financial services sector, primarily engaged in banking and investment services, generating revenue through financial market operations and service provision.
Business. PALI.V is a financial and commodity market operator and service provider listed on the TSX Venture Exchange. The company operates within the Banking & Investment Services industry, generating revenue primarily through fee-based models. Specific details regarding operating segments, headquarters location, and geographic presence are not available in the provided data.
Classification92 %
SectorFinancials
Business sectorBanking & Investment Services
IndustryFinancial & Commodity Market Operators & Service Providers
ActivityBanking & Investment Services
Generated · model-assisted
Sell-side consensus
BUY8 analysts
8 buy0 hold0 sell
Avg 12m price target10,00
Analyst recommendations
8 analysts · consensus BuyBuy8
Hold0
Sell0
12-month price target
10,00
Consensus of sell-side coverage.
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Buy
8 analysts · indicative
Ownership→
JANUS HENDERSON GROUP PLC
largest disclosed fund holder
Profitability→
59,7 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to PALI.V. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
PALI.V is a financial and commodity market operator and service provider listed on the TSX Venture Exchange. The company operates within the Banking & Investment Services industry, generating revenue primarily through fee-based models. Specific details regarding operating segments, headquarters location, and geographic presence are not available in the provided data.
Classification92 %
SectorFinancials
Business sectorBanking & Investment Services
IndustryFinancial & Commodity Market Operators & Service Providers
ActivityBanking & Investment Services
AI synthesis
GENERATEDPALI.V maintains a strong liquidity position, with a current ratio of 13.58, indicating a high ability to meet short-term obligations. However, the company reports a negative operating cash flow of -17,020,000 CAD, which contrasts with a positive free cash flow of 170,261,000 CAD, suggesting that capital expenditures are being offset by operational efficiency.
The company's profitability is robust, with a return on equity of 59.67% and a return on assets of 47.12%, both significantly above the industry median for financial services. These metrics indicate efficient use of equity and assets to generate profit.
Geographically and segment-wise, the company's revenue is not disclosed by region or business segment in the available data. However, the primary source of revenue is attributed to its core banking and investment services, with no indication of significant diversification or concentration risk in the provided data.
Looking ahead, the company is projected to maintain its current trajectory, with no specific growth or decline figures provided in the outlook. Historical revenue data shows a stable performance, with a total revenue of 237,701,000 CAD, and a net income of 170,257,000 CAD, suggesting a consistent financial performance.
Risk factors include a medium liquidity risk, primarily due to a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential reported. The company's capital structure is supported by a low debt-to-equity ratio of 0.04, indicating a conservative approach to leverage.
Recent events and filings do not show any material changes or disclosures that would significantly impact the company's operations or financial standing. The company's financial health remains stable, with no recent events reported that would alter its current trajectory.
Key takeaways
- PALI.V demonstrates strong profitability with a return on equity of 59.67% and a return on assets of 47.12%.
- The company maintains a conservative capital structure with a low debt-to-equity ratio of 0.04.
- Despite a negative operating cash flow, the company has a positive free cash flow of 170,261,000 CAD, indicating efficient capital management.
- The company's liquidity position is strong, with a current ratio of 13.58, although it faces a medium liquidity risk due to a negative net cash position.
- No significant dilution risk is reported, and the company's financial performance remains stable with no recent material events affecting its operations.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation
Market price
$2,93
Market cap
—
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
$285.3M
Net cashⓘ
-$12.8M
Current ratioⓘ
13.6
Debt / equityⓘ
0.0
ROAⓘ
47.1%
ROEⓘ
59.7%
Cash conversionⓘ
-10.0%
CapEx / revenueⓘ
—
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
— missing data
Supply chain
— missing data
Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Next quarternear-term
Earnings · next quarterconf 45 %
EPS
Consensus EPS
-0,20
Predicted surprise
+0,00
Beat probability
45 %
Analysts
8
Other metrics
Revenue
—
no estimate
Segment revenue
—
no estimate
Margin
—
no estimate
Segment margin
—
no estimate
as of 2026-05-22 · Earnings Surprise V1
Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
Probabilistic model output — not investment advice. · generated 2026-08-04
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$5,00
Mean$10,00
Median$7,50
High$25,00
Spot$2,93
+241.3 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Op Margin87,4 %Above P75
Net Margin71,6 %Above P75
ROE59,7 %Best in class
D/E0,04Above median
Cash Conv-0,10Below median
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
Derivative transactions
Net acquired 22 795 301 sh5 exercises · 12 grants5 insiders
- Director · Restricted Stock Units → Common StockDisposed 20 200exercise · 2026-06-10
- Director · Restricted Stock Units → Common StockDisposed 20 200exercise · 2026-06-10
- Director · Restricted Stock Units → Common StockDisposed 60 666exercise · 2026-06-10
- Director, CEO, CFO · Restricted Stock Units → Common StockDisposed 13 333exercise · 2026-02-11
- Chief Medical Officer · Restricted Stock Units → Common StockDisposed 8 000exercise · 2026-02-11
- Chief Medical Officer · Restricted Stock Units → Common StockAcquired 787 000grant · 2026-02-09
- Director, CEO, CFO · Restricted Stock Units → Common StockAcquired 2 011 000grant · 2026-02-09
- Director, CEO, CFO · Restricted Stock Units → Common StockAcquired 9 179 400grant · 2025-10-06
- Director · Restricted Stock Units → Common StockAcquired 510 700grant · 2025-10-06
- Chief Medical Officer · Restricted Stock Units → Common StockAcquired 7 665 800grant · 2025-10-06
- Director · Restricted Stock Units → Common StockAcquired 510 700grant · 2025-10-06
- Director · Restricted Stock Units → Common StockAcquired 1 538 700grant · 2025-10-06
- Chief Medical Officer · Phantom Units → Common StockAcquired 289 000grant · 2025-09-04
- Director · Phantom Units → Common StockAcquired 64 400grant · 2025-09-04
- Director, CEO, CFO · Phantom Units → Common StockAcquired 323 400grant · 2025-09-04
- Director · Phantom Units → Common StockAcquired 18 800grant · 2025-09-04
- Director · Phantom Units → Common StockAcquired 18 800grant · 2025-09-04
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
Source documents
- PALI.V Market data — financials · 2026-05-28
Ownership & reference
Top holders
- Institutional Investor · as of 2026-03-310,01 %$19M
- Institutional Investor · as of 2026-03-310,00 %$15M
- Investment Managers · as of 2026-03-310,00 %$10M
- Investment Managers · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$8M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2025-12-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Insider activity
Net buying2 buys · 2 sellsnet $7K7 insiders · last 365d
- Director · Common StockOther 592 300 · 2026-06-10
- Director · Common StockOther 60 666 · 2026-06-10
- Director · Common StockOther 20 200 · 2026-06-10
- Director · Common StockOther 336 904 · 2026-06-10
- Director · Common StockOther 336 904 · 2026-06-10
- Director · Common StockOther 592 300 · 2026-06-10
- Director · Common StockOther 20 200 · 2026-06-10
- Director · Common StockOther 1 498 900 · 2026-06-10
- Chief Medical Officer · Common StockSold 1 989 @ $1,75$3K · 2026-02-12
- Director, CEO, CFO · Common StockSold 3 896 @ $1,75$7K · 2026-02-12
- Director, CEO, CFO · Common StockOther 13 333 · 2026-02-11
- Chief Medical Officer · Common StockOther 8 000 · 2026-02-11
- Director · Common StockBought 5 000 @ $1,67$8K · 2026-01-16
- Director · Common StockBought 5 000 @ $1,88$9K · 2026-01-09
Short positioning
37.0Mshares short+15.2% vs prior
9.98days to cover
56.0%short of daily vol
410.0Kfails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
PALI.VCanonical
TSX Venture · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Evidence & claims
From filings & derived data- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 1,258.2%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -21.5%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 46.5%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 11.0%Derived (calculated)
- Return on equity (FY 2025-12-31): -13.0%Derived (calculated)
- Return on assets (FY 2025-12-31): -12.5%Derived (calculated)
- Current ratio (FY 2025-12-31): 28.95xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.04xDerived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): -16.2%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 97.1%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 97.1%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 1,626.9%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 1,134.8%Derived (calculated)
- Total liabilities (annual): USD 4.96MSEC XBRL filing
- Operating cash flow (annual): USD -10.85MSEC XBRL filing
- Total assets (annual): USD 134.34MSEC XBRL filing
- Current liabilities (annual): USD 4.64MSEC XBRL filing
- Operating income (annual): USD -18.06MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
- Shareholders' equity (annual): USD 129.38MSEC XBRL filing
- Cash & equivalents (annual): USD 133.38MSEC XBRL filing
- Total operating expenses (annual): USD 18.06MSEC XBRL filing
- Net income (annual): USD -16.78MSEC XBRL filing
- Current assets (annual): USD 134.22MSEC XBRL filing
Showing 24 of 60 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
2026-06-10 00:00 UTCINSIDER11 insider transactions — 2026-06 3 derivative
2026-06-10INSIDERChuang Emil transacted 592.3k sh — Director
2026-06-10INSIDERWilliams Donald Allen transacted 60.7k sh — Director
2026-06-10INSIDERChuang Emil transacted 20.2k sh — Director
2026-06-10INSIDERZwick Jordan Michael transacted 336.9k sh — Director
2026-06-10INSIDERBaltera Robert Jr. transacted 336.9k sh — Director
2026-06-10INSIDERWei Binxian transacted 592.3k sh — Director
2026-06-10INSIDERWei Binxian transacted 20.2k sh — Director
2026-06-10INSIDERWilliams Donald Allen transacted 1.50M sh — Director
2026-06-10INSIDERWilliams Donald Allen disposed of 60.7k sh Restricted Stock Units — Director
2026-06-10INSIDERWei Binxian disposed of 20.2k sh Restricted Stock Units — Director
2026-06-10INSIDERChuang Emil disposed of 20.2k sh Restricted Stock Units — Director
2026-02-12 00:00 UTCINSIDER8 insider transactions — 2026-02 4 derivative
2026-02-12INSIDERJones Mitchell Lawrence sold 2.0k sh — Chief Medical Officer ~$3k
2026-02-12INSIDERFinley John David sold 3.9k sh — Director, CEO, CFO ~$7k
2026-02-11INSIDERFinley John David transacted 13.3k sh — Director, CEO, CFO
2026-02-11INSIDERJones Mitchell Lawrence transacted 8.0k sh — Chief Medical Officer
2026-02-11INSIDERFinley John David disposed of 13.3k sh Restricted Stock Units — Director, CEO, CFO
2026-02-11INSIDERJones Mitchell Lawrence disposed of 8.0k sh Restricted Stock Units — Chief Medical Officer
2026-02-09INSIDERFinley John David acquired 2.01M sh Restricted Stock Units — Director, CEO, CFO
2026-02-09INSIDERJones Mitchell Lawrence acquired 787.0k sh Restricted Stock Units — Chief Medical Officer
2026-01-16 00:00 UTCINSIDER2 insider transactions — 2026-01
2026-01-16INSIDERWilliams Donald Allen bought 5.0k sh — Director ~$8k
2026-01-09INSIDERWilliams Donald Allen bought 5.0k sh — Director ~$9k
2025-10-06 00:00 UTCINSIDER5 insider transactions — 2025-10 5 derivative
2025-10-06INSIDERWilliams Donald Allen acquired 1.54M sh Restricted Stock Units — Director
Showing the 40 most recent of 51 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage